Supported by the Swiss National Science Foundation (SNSF) within the framework of the National Research Programme "Covid-19" (NRP 78) Grant-N° 40780_198403, an unconditional research grant including free investigational medicinal product of Pharming Biotechnologies B.V., Leiden, The Netherlands, and departmental funds of MO (University Hospital Basel).
Pharming Biotechnologies B.V. was involved in the design of the study at an initial stage and in the organization of the study in Brazil and Mexico. The funders will have no role in collection, management, analysis and interpretation of the data, preparation of the manuscript, or the decision to submit the manuscript for publication.